Asarina Pharma AB (STU:APS) Price-to-Tangible-Book : 3.22 (As of May. 30, 2024)

View and export this data going back to 2020. Start your Free Trial

What is Asarina Pharma AB Price-to-Tangible-Book?

As of today (2024-05-30), Asarina Pharma AB's share price is €0.0676. Asarina Pharma AB's Tangible Book per Share of Jun. 2023 for the quarter that ended in Jun. 2023 was €0.02. Hence, Asarina Pharma AB's Price to Tangible Book Ratio of today is 3.22.

The historical rank and industry rank for Asarina Pharma AB's Price-to-Tangible-Book or its related term are showing as below:

STU:APS' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.27 Med: 2.84 Max: 4.81
Current: 3.38

During the past 6 years, Asarina Pharma AB's highest Price to Tangible Book Ratio was 4.81. The lowest was 1.27. And the median was 2.84.

STU:APS's Price-to-Tangible-Book is ranked worse than
58.28% of 1220 companies
in the Biotechnology industry
Industry Median: 2.775 vs STU:APS: 3.38

A closely related ratio is called PB Ratio. As of today, Asarina Pharma AB's share price is €0.0676. Asarina Pharma AB's Book Value per Sharefor the quarter that ended in Jun. 2023 was €0.02. Hence, Asarina Pharma AB's P/B Ratio of today is 3.22.

Asarina Pharma AB Price-to-Tangible-Book Historical Data

The historical data trend for Asarina Pharma AB's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Asarina Pharma AB Price-to-Tangible-Book Chart

Asarina Pharma AB Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.17

1.68

1.27

Asarina Pharma AB Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Dec22	Jun23
Price-to-Tangible-Book	Get a 7-Day Free Trial															1.68	1.75	1.27	1.27	3.00

Competitive Comparison of Asarina Pharma AB's Price-to-Tangible-Book

For the Biotechnology subindustry, Asarina Pharma AB's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asarina Pharma AB's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asarina Pharma AB's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Asarina Pharma AB's Price-to-Tangible-Book falls into.

Asarina Pharma AB Price-to-Tangible-Book Calculation

Asarina Pharma AB's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Jun. 2023 )
	=	0.0676	/	0.021
	=	3.22

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Asarina Pharma AB Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Asarina Pharma AB's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Asarina Pharma AB (STU:APS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asarina Pharma AB (STU:APS) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

ASAP:Sweden

Address

Fogdevreten 2, Karolinska Institutet Science Park, Solna, SWE, SE-171 65

Website

https://www.asarinapharma.com

Asarina Pharma AB is a Swedish biotech company developing Sepranolone for Allopregnanolone-related stress, compulsion and neurological disorders. Its product pipeline is built on over 40 years of research into llopregnanolone-related neurological disorders. With the new family of GAMSA compounds (GABA-A Modulating Steroid Antagonists) the company aims to deliver a new generation of efficacious and safe drugs for still widely untreated neuroendocrinological conditions.

Asarina Pharma AB (STU:APS) Headlines

No Headlines